EP0223420A1 — Condensed imidazopyridine derivatives
Assigned to Shionogi and Co Ltd · Expires 1987-05-27 · 39y expired
What this patent protects
Condensed imidazopyridine derivatives. (wherein R is phenyl optionally substituted by one or two members selected from the group consisting of trifluoromethyl, C 1 -C 5 alkyl, C 1 -C 5 alkoxy, C 1 -C 5 alkylthio, nitro, amino C 1 -C 5 alkanoylamino and C,-C5 alkoxycarbon…
USPTO Abstract
Condensed imidazopyridine derivatives. (wherein R is phenyl optionally substituted by one or two members selected from the group consisting of trifluoromethyl, C 1 -C 5 alkyl, C 1 -C 5 alkoxy, C 1 -C 5 alkylthio, nitro, amino C 1 -C 5 alkanoylamino and C,-C5 alkoxycarbonyl or 5-or 6-membered heterocyclic group optionally substituted by one or two members selected from the group consisting of halogen, C 1 -C 5 alkyl and C 1 -C 5 alkoxy, Q is hydrogen, C 1 -C 5 alkyl, C 1 -C 10 acyl, C,-Cs alkylsulfonyl or Cs-C,o arylsulfonyl, R', R 2 , R 3 , and R 4 each is hydrogen, halogen C 1 -C 5 alkyl, C,-C s alkoxy or C,-C s haloalkyl, Q is present on the nitrogen atom of the 1,3 or 5-position and the dotted line indicates the presence of three double bonds at the position of 2, 3; 3a, 3b; 4, 5 / 1, 3b; 2, 3; 3a, 4 / or 1, 2; 3a, 3b; 4, 5) or its salt, being useful as psychostimulants or anxiolytics, is provided.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.